AnnexinA5 Might Suppress the Phenotype of Human Gastric Cancer Cells via ERK Pathway
Open Access
- 12 May 2021
- journal article
- retracted article
- Published by Frontiers Media SA in Frontiers in Oncology
Abstract
Gastric cancer is one of the most fatal diseases around the world. However, the mechanism of the development of gastric cancer is still not clarified. In addition, the anticancer drugs have cytotoxicity with different degrees. AnnexinA5, a member of the annexin family, has a great binding ability with the membrane phospholipid in a calcium dependent manner and is involved in the development of various cancers. This study aims to explore the influence of annexinA5 on human gastric cancer cells and whether it has the potential to be an auxiliary treatment to gastric cancer. In this study, the role of annexinA5 was detected from both the endogenous and the exogenous aspects on the gastric cancer cell lines MGC-803 and MKN-45. The cells were divided into a knockdown group in which RNA interference technique was used to suppress annexinA5 expression and a protein-supplementing group in which annexinA5 protein was added in the culture supernatant. After the suppression ratio of RNA interference was determined and the IC50 of annexinA5 protein was decided respectively, the cells’ proliferation was detected by MTT assay, colony formation assay, and the expression of PCNA. FCM assay and PI staining methods were applied to test cell apoptosis and necrosis. To investigate whether ANXA5 influence cell metastasis, wound healing assay and transwell assay were employed. To further detect the mechanism of annexinA5 action, the signal pathway was examined with Western Blot method. When ANXA5 gene was knocked down, cell proliferation and metastasis were promoted, while cell apoptosis was suppressed. On the other hand, after the annexinA5 protein was applied to the gastric cancer cells, cell proliferation and metastasis were inhibited, while cell apoptosis and necrosis were promoted. AnnexinA5 played its role via ERK signal pathway. ANXA5 acted as tumor suppressor gene in the gastric cancer by suppressing ERK signal pathway and has the potentiality to be an auxiliary anticancer agent.This publication has 23 references indexed in Scilit:
- In Vivo Apoptosis Imaging Using Site-Specifically 68Ga-Labeled Annexin VMethods in Molecular Biology, 2016
- Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signalingOncology Reports, 2014
- Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cellsTumor Biology, 2014
- Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapyScientific Reports, 2013
- Annexin A5 protein expression is associated with the histological differentiation of uterine cervical squamous cell carcinoma in patients with an increased serum concentrationMolecular Medicine Reports, 2012
- Annexin 5 overexpression increased articular chondrocyte apoptosis induced by basic calcium phosphate crystalsAnnals Of The Rheumatic Diseases, 2008
- Annexin V/β5 Integrin Interactions Regulate Apoptosis of Growth Plate ChondrocytesOnline Journal of Public Health Informatics, 2006
- DT40 cells lacking the Ca 2+ -binding protein annexin 5 are resistant to Ca 2+ -dependent apoptosisProceedings of the National Academy of Sciences of the United States of America, 2002
- Annexins: From Structure to FunctionPhysiological Reviews, 2002